Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study.
Saved in:
| Title: | Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study. |
|---|---|
| Authors: | Affinito, Giuseppina (AUTHOR), Trama, Ugo (AUTHOR), Palumbo, Laura (AUTHOR), Fumo, Maria Grazia (AUTHOR), Giordana, Roberta (AUTHOR), Di Gennaro, Massimo (AUTHOR), Triassi, Maria (AUTHOR), Lanzillo, Roberta (AUTHOR), Morra, Vincenzo Brescia (AUTHOR), Palladino, Raffaele (AUTHOR), Moccia, Marcello (AUTHOR) |
| Source: | Neurological Sciences. Nov2023, Vol. 44 Issue 11, p3771-3779. 9p. |
| Subjects: | Multiple sclerosis, COVID-19, Medical care, COVID-19 pandemic, Patient compliance |
| Geographic Terms: | Campania (Italy) |
| Abstract: | Background: COVID-19 pandemic has affected the management of multiple sclerosis (MS). Objective: To explore the impact of COVID-19 on healthcare delivery to people with MS and the subsequent recovery of the system. Methods: In this population-based study in the Campania Region (Italy), we included people with MS across pre-COVID-19, lockdown, pre-vaccination, and vaccination periods. Differences in continuous outcomes between periods were explored using linear mixed models (annualized hospitalization rate (AHR) and adherence measured as medication possession ratio (MPR)). Differences in disease-modifying treatment (DMT) prescription rates (first DMT prescription, any DMT switch, switch from platform to highly effective DMT, and combination of first DMT prescription and any DMT switch) were assessed using an interrupted time series design. Results: Compared with pre-COVID-19, AHR decreased during the lockdown (Coeff = 0.64;95%CI = -0.69, -0.59; p < 0.01), and remained lower during pre-vaccination and vaccination periods. Adherence decreased during pre-vaccination (Coeff = -0.04;95%CI = -0.05, -0.03; p < 0.01) and vaccination periods (Coeff = -0.07;95%CI = -0.08, -0.07; p < 0.01). After the lockdown, there was an increase in any DMT switch (IRR 2.05 95%CI 1.38,3.05; p < 0.01), in switch from platform to highly effective DMTs (IRR 4.45;95%CI 2.48,8.26; p < 0.01) and in first DMT prescriptions (IRR 2.48;95%CI 1.64,3.74; p < 0.01). Conclusions: DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 172948296 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Affinito%2C+Giuseppina%22">Affinito, Giuseppina</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Trama%2C+Ugo%22">Trama, Ugo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Palumbo%2C+Laura%22">Palumbo, Laura</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fumo%2C+Maria+Grazia%22">Fumo, Maria Grazia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Giordana%2C+Roberta%22">Giordana, Roberta</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Gennaro%2C+Massimo%22">Di Gennaro, Massimo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Triassi%2C+Maria%22">Triassi, Maria</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lanzillo%2C+Roberta%22">Lanzillo, Roberta</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morra%2C+Vincenzo+Brescia%22">Morra, Vincenzo Brescia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Palladino%2C+Raffaele%22">Palladino, Raffaele</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moccia%2C+Marcello%22">Moccia, Marcello</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Nov2023, Vol. 44 Issue 11, p3771-3779. 9p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Multiple+sclerosis%22">Multiple sclerosis</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care%22">Medical care</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+compliance%22">Patient compliance</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Campania+%28Italy%29%22">Campania (Italy)</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: COVID-19 pandemic has affected the management of multiple sclerosis (MS). Objective: To explore the impact of COVID-19 on healthcare delivery to people with MS and the subsequent recovery of the system. Methods: In this population-based study in the Campania Region (Italy), we included people with MS across pre-COVID-19, lockdown, pre-vaccination, and vaccination periods. Differences in continuous outcomes between periods were explored using linear mixed models (annualized hospitalization rate (AHR) and adherence measured as medication possession ratio (MPR)). Differences in disease-modifying treatment (DMT) prescription rates (first DMT prescription, any DMT switch, switch from platform to highly effective DMT, and combination of first DMT prescription and any DMT switch) were assessed using an interrupted time series design. Results: Compared with pre-COVID-19, AHR decreased during the lockdown (Coeff = 0.64;95%CI = -0.69, -0.59; p < 0.01), and remained lower during pre-vaccination and vaccination periods. Adherence decreased during pre-vaccination (Coeff = -0.04;95%CI = -0.05, -0.03; p < 0.01) and vaccination periods (Coeff = -0.07;95%CI = -0.08, -0.07; p < 0.01). After the lockdown, there was an increase in any DMT switch (IRR 2.05 95%CI 1.38,3.05; p < 0.01), in switch from platform to highly effective DMTs (IRR 4.45;95%CI 2.48,8.26; p < 0.01) and in first DMT prescriptions (IRR 2.48;95%CI 1.64,3.74; p < 0.01). Conclusions: DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=172948296 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10072-023-07052-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 3771 Subjects: – SubjectFull: Multiple sclerosis Type: general – SubjectFull: COVID-19 Type: general – SubjectFull: Medical care Type: general – SubjectFull: COVID-19 pandemic Type: general – SubjectFull: Patient compliance Type: general – SubjectFull: Campania (Italy) Type: general Titles: – TitleFull: Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Affinito, Giuseppina – PersonEntity: Name: NameFull: Trama, Ugo – PersonEntity: Name: NameFull: Palumbo, Laura – PersonEntity: Name: NameFull: Fumo, Maria Grazia – PersonEntity: Name: NameFull: Giordana, Roberta – PersonEntity: Name: NameFull: Di Gennaro, Massimo – PersonEntity: Name: NameFull: Triassi, Maria – PersonEntity: Name: NameFull: Lanzillo, Roberta – PersonEntity: Name: NameFull: Morra, Vincenzo Brescia – PersonEntity: Name: NameFull: Palladino, Raffaele – PersonEntity: Name: NameFull: Moccia, Marcello IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 15901874 Numbering: – Type: volume Value: 44 – Type: issue Value: 11 Titles: – TitleFull: Neurological Sciences Type: main |
| ResultId | 1 |